N1VO34:BVMF
Novo Nordisk Bdr
23,92 BRL
arrow_downward
−0,33%(−0,080) 1D
13. lis, 16:56:00 GMT -3 · BRL
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za N1VO34...
Otvori
24,01 BRL
Najviša
24,36 BRL
Najniža
23,80 BRL
Trž. kap.
128,51 mlr.
Prosj. kol.
34,82 tis.
Količina
8,45 tis.
52-tjed. najviša
42,43 BRL
52-tjed. najniža
22,90 BRL
Dionice u optjecaju
3,39 mlr.
Broj djelatnika
67 tis.
Otvori
24,01 BRL
Najviša
24,36 BRL
Najniža
23,80 BRL
Trž. kap.
128,51 mlr.
Prosj. kol.
34,82 tis.
Količina
8,45 tis.
52-tjed. najviša
42,43 BRL
52-tjed. najniža
22,90 BRL
Dionice u optjecaju
3,39 mlr.
Broj djelatnika
67 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
The Motley Fool
·
prije 1 sat
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance
·
prije 2 sata
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
TipRanks
·
prije 11 sati
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Zacks Investment Research
·
prije 1 dan
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Profil
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk Bdr – informacije
Glavni izvršni direktorMaziar Mike Doustdar
Zaposlenici66,7 tis.
Osnovano1923
SjedišteBagsværd, Hovedstaden, Danska
Sektor-
Web-lokacijanovonordisk.com